FolioLanternBeta
WVEWave Life Sciences, Inc.

Kyle Moran

Chief Financial Officer at Wave Life Sciences, Inc., as of Feb 11, 2026Sold $4.2M of stock in the past 12 months: 99% under a disclosed plan and 1% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
264K
shares sold, past 12 months
3
days with sales
$3.1M
largest single day, Dec 8, 2025
1
company filed for

Share of stake sold and shares held at Wave Life Sciences, Inc. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $4.1M under a disclosed plan$4.1MDecJanFeb 2026: $48K to cover taxesFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Wave Life Sciences, Inc. (WVE)Chief Financial OfficerDec 11, 2020Feb 11, 2026

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.